Ace Therapeutics provides comprehensive preclinical antipsychotic drug screening services, and we aim to help you save time and money by accelerating your drug development process.

Introduction of Antipsychotics Screening

Antipsychotic screening refers to the process of evaluating the biological activity, pharmacological action, and medicinal value of substances that may be used as antipsychotics by using appropriate methods at the cellular and biochemical levels. Antipsychotic screening is a key step in the discovery of new antipsychotics. Many studies have proved that the dysfunction of protein kinases, ion channels, membrane transporters, and G protein-coupled receptors (GPCR) will lead to the occurrence of a variety of neuropsychiatric diseases due to the complex signal transduction mode of the nervous system, which has become a variety of targets involved in the study of mental diseases. Therefore, antipsychotics can be screened from these targets.

Antipsychotics Screening Services

Ace Therapeutics leverages specialized technologies and advanced platforms to help our clients explore the mysteries of mental illness and shorten the time to antipsychotic drug discovery and research. Our technology platform better meets the yield, cost, and time challenges that arise in providing antipsychotic drug screening services. With our extensive scientific experience, our team of professionals can rapidly build large-scale transcriptomic databases of candidate antipsychotic drug responses, providing a data base for the study of antipsychotic drug mechanisms and even antipsychotic drug resistance mechanisms. Based on the targets you provide, we will analyze and evaluate antipsychotic drug screening methods and become the backbone of your R&D efforts.

Antipsychotic Screening Services We Can Provide

Ace Therapeutics can provide almost everything you need to implement a preclinical testing program for antipsychotic drugs and take some of the guesswork out of the process. Our screening services include

• Protein Kinase Screening of Antipsychotics
• Ion Channel Screening Process of Antipsychotics
• Membrane Transporter Screening of Antipsychotics
• GPCR Screening of Antipsychotics

Antipsychotic Drug Screening Process

1. You submit your requirements for antipsychotic drug screening. This includes sample type, basic properties, requirements for viable systems or cell lines, target selection, project duration, acceptance index, and other screening-related requirements.
2. We perform a comprehensive evaluation of the drug screening program. The above requirements are submitted in the form of a project specification, which is evaluated internally based on the experimental system, work intensity, expected time, associated costs, and other indicators.
3. Both parties discuss and exchange other details of the project.
4. We select the screening method, determine the experimental protocol, and sign the service agreement.
5. We carry out the work and summarize the results in the form of an experimental report. We complete the project on time according to the agreed time, summarize the experimental data and conclusions, complete the experimental report, and provide the experimental data requested by the client.
6. Acceptance of results and follow-up services.

Ace Therapeutics provides high-quality analytical services required throughout the preclinical development of antipsychotic drugs. We welcome projects of any size and our scientists will be happy to help you determine the best solution for your project, please make an inquiry for more information.

Reference

1. Yadav M, et al. Possible biomarkers and contributing factors of psychosis: a review. Curr Pharmacol Rep. 2021, 7: 123-134.

• Neurotransmitter Receptors, Transporters, and Ion Channels